Ikarian Capital, LLC Biomea Fusion, Inc. Put Options Transaction History

Ikarian Capital, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$4.23 - $10.1 $224,190 - $535,300	53,000 New	53,000 $535,000
Q1 2024 May 15, 2024	SELL	$13.92 - $19.5 $5.53 Million - $7.74 Million	-397,000 Reduced 79.4%	103,000 $1.54 Million
Q4 2023 Feb 14, 2024	BUY	$8.37 - $19.8 $4.18 Million - $9.9 Million	500,000 New	500,000 $7.26 Million
Q2 2023 Aug 14, 2023	BUY	$21.66 - $41.8 $5.34 Million - $10.3 Million	246,700 Added 616.75%	286,700 $6.29 Million
Q1 2023 May 15, 2023	BUY	$6.8 - $32.35 $272,000 - $1.29 Million	40,000 New	40,000 $1.24 Million

104

17.8M

1.68M

410K

Ticker BMEA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,290,600
Market Cap $120M
Description
Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.